BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32276412)

  • 21. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
    Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
    Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
    Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
    Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
    Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
    Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.
    Jin XF; Spampatti MP; Spitzweg C; Auernhammer CJ
    Rev Endocr Metab Disord; 2018 Jun; 19(2):145-158. PubMed ID: 29464446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone health and vitamin D status in alcoholic liver disease.
    Kizilgul M; Ozcelik O; Delibasi T
    Indian J Gastroenterol; 2016 Jul; 35(4):253-9. PubMed ID: 27246833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
    Barrea L; Muscogiuri G; Pugliese G; Modica R; Laudisio D; Aprano S; Faggiano A; Colao A; Savastano S
    J Transl Med; 2021 Jul; 19(1):324. PubMed ID: 34330303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.
    Linari S; Montorzi G; Bartolozzi D; Borderi M; Melchiorre D; Benelli M; Morfini M
    Haemophilia; 2013 Jan; 19(1):126-33. PubMed ID: 22776099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D Deficiency and Its Influence on Bone Metabolism and Density in a Brazilian Population of Healthy Men.
    Moreira ML; Neto LV; Madeira M; Lopes RF; Farias MLF
    J Clin Densitom; 2018; 21(1):91-97. PubMed ID: 28233710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone metabolism and vitamin D status in patients with multiple sclerosis.
    Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitamin D deficiency and osteoporosis in a rural population of Cordoba province, Argentina].
    Gobbi C; Salica D; Pepe G; Dotto G; Petenian E; Martínez F
    Rev Fac Cien Med Univ Nac Cordoba; 2009; 66(3):103-12. PubMed ID: 21138667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
    J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4.
    Stavroulopoulos A; Porter CJ; Roe SD; Hosking DJ; Cassidy MJ
    Nephrology (Carlton); 2008 Feb; 13(1):63-7. PubMed ID: 18199106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
    Guo LJ; Wang CH; Tang CW
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional and vitamin status in patients with neuroendocrine neoplasms.
    Clement DS; Tesselaar ME; van Leerdam ME; Srirajaskanthan R; Ramage JK
    World J Gastroenterol; 2019 Mar; 25(10):1171-1184. PubMed ID: 30886501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
    Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
    Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic inflammatory mediators and bone homeostasis in intestinal failure.
    Compher C; Pazianas M; Benedict S; Brown JC; Kinosian BP; Hise M
    JPEN J Parenter Enteral Nutr; 2007; 31(2):142-7. PubMed ID: 17308255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.